Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulating the Microbiome for Crohn’s Disease Treatment
Rachael Gowen, Ahmed Gamal, Luca Di Martino, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 828-840
Open Access | Times Cited: 19

Showing 19 citing articles:

Responsively Degradable Nanoarmor‐Assisted Super Resistance and Stable Colonization of Probiotics for Enhanced Inflammation‐Targeted Delivery
Limeng Zhu, Tiantian Yu, Wenchao Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 17
The gut ecosystem and immune tolerance
Tihong Shao, Ronald Hsu, Desiree L. Rafizadeh, et al.
Journal of Autoimmunity (2023) Vol. 141, pp. 103114-103114
Open Access | Times Cited: 31
Oral and Fecal Microbiota as Accurate Non-invasive Tools for Detection of Pancreatic Cancer in the Chinese Population
Pengyu Li, Hanyu Zhang, Lixin Chen, et al.
Cancer Letters (2025) Vol. 612, pp. 217456-217456
Closed Access
Specific Composition Diets and Improvement of Symptoms of Immune-Mediated Inflammatory Diseases in Adulthood—Could the Comparison Between Diets Be Improved?
María Dolores Guerrero Aznar, M Dolores Villanueva Guerrero, Margarita Beltrán García, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 493-493
Open Access
The Role of the Gut Microbiome in Immune Dysregulation and Pathogenesis of Inflammatory Bowel Disease
Madiha Tariq, Haleem Khan, Maryam Gulzar, et al.
Developmental medico-life-sciences (2025) Vol. 2, Iss. 1, pp. 13-25
Closed Access
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Fabrication of levofloxacin-loaded porcine acellular dermal matrix hydrogel and functional assessment in urinary tract infection
Yi Yang, Guangwei Yang, Jian-Juan Lu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering
Oliver Sandys, Pieter Stokkers, Anje A. te Velde
Digestive Diseases and Sciences (2024)
Open Access | Times Cited: 2
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn’s disease is suppressed by rfaP and ybaT deletion
Gabriella Leccese, Matteo Chiara, Irene Dusetti, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Probiotics modulation of the endotoxemic effect on the gut and liver of the lipopolysaccharide challenged mice
Gyan Babu, Banalata Mohanty
Drug and Chemical Toxicology (2024), pp. 1-17
Closed Access | Times Cited: 1
Antibiotic Conditioning Shapes Pseudosterile Mouse Models by Deleting Colonic Microbes Rather than Small Intestinal Microbes
Qingxue Chen, Ma Xinming, Zhishuang Xing, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 3
Probiotic supplementation of pea-derived protein alters the gut microbiome balance in favor of increased protein degradation, reflected in increased levels of essential amino acid in human plasma
Mauricio Retuerto, Michael B. LaMonica, Tim N. Ziegenfuss, et al.
Gastroenterology & Hepatology Open Access (2023) Vol. 14, Iss. 4, pp. 93-103
Open Access | Times Cited: 3
The Impact of Faecal Diversion on the Gut Microbiome: A Systematic Review
Shien Wenn Sam, Bilal Hafeez, Hwa Ian Ong, et al.
Gut Microbiome (2024) Vol. 5
Open Access
Gut microbiota composition in patients with Crohn’s disease in Saudi Arabia
Hadil Alahdal, Ghaida Almuneef, Manal Muhammed Alkhulaifi, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299749-e0299749
Open Access
Polysaccharides from Trametes versicolor as a Potential Prebiotic to Improve the Gut Microbiota in High-Fat Diet Mice
Ming Bai, Zhenfeng Huang, Xiaoya Zheng, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1654-1654
Open Access
Colonic long-term retention and colonization of probiotics by double-layer chitosan/tannic acid coating and microsphere embedding for treatment of ulcerative colitis and radiation enteritis
Rui Sun, Shumin Du, Minting Wang, et al.
International Journal of Biological Macromolecules (2024), pp. 135757-135757
Closed Access
Perceptions and emotions in postoperative recovery of patients with perianal diseases
Bryan Adrián Priego-Parra, J.M. Remes-Troche
World Journal of Psychiatry (2024) Vol. 15, Iss. 1
Closed Access
Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process
Aisha Arkan Ahmed, Antonius T. Otten, Bahez Gareb, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1354-1354
Open Access | Times Cited: 1
Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”
Eirini Filidou, George Kolios
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 714-714
Open Access
Physiological modulation of adipogenic transcription factors: A possible therapeutic target for the prevention of metabolic pathologies-related oxido-inflammatory responses
Mega O. Oyovwi, Ojetola AA, Onome Bright Oghenetega, et al.
Gastroenterology & Hepatology Open Access (2023) Vol. 14, Iss. 4, pp. 105-11
Open Access
Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease
С. И. Ситкин, Juris Pokrotnieks
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 11, pp. e40-e41
Open Access
Page 1

Scroll to top